 |
|
LMB-9 immunotoxin
A recombinant disulfide stabilized anti-Lewis Y IgG immunotoxin containing a 38 KD toxic element derived from the Pseudomonas aeruginosa exotoxin A and a monoclonal antibody fragment, designed to target adenocarcinomas expressing Lewis Y. LMB-9 immunotoxin attaches to tumor cells, facilitating he entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | B3 (dsFv)-PE38
LMB-9 | | |
| Previous: | live freeze-dried lactic acid bacteria probiotic, live-attenuated Listeria encoding human mesothelin vaccine CRS-207, LMB-1 immunotoxin, LMB-2 immunotoxin, LMB-7 immunotoxin | | Next: | lobradimil, Lodine, lometrexol, lomustine, lonafarnib |
|
|
